Skip to main content

Table 4 Percentage of facilities with drugs in stock for HIV and malaria, by type of facility and year

From: The triple threat of pregnancy, HIV infection and malaria: reported causes of maternal mortality in two nationwide health facility assessments in Mozambique, 2007 and 2012

  Central, Provincial & General Hospitals Rural & District Hospitals Health Centers & Posts Total
2007 2012 2007 2012 2007 2012 2007 2012
  n = 16 n = 14 n = 26 n = 41a n = 347 n = 891 n = 389 n = 946
  % (wt) % % (wt) % % (wt) % % (wt) %
Antiretrovirals         
 Nevirapine 71 93 74 93 23 88 26 88
 AZT 65 100 74 83 20 81 23 81
 3TC + AZT/D4T 71 na 73 na 18 na 21 na
 3TC na 86 na 73 na 59 na 60
Antimalarials         
Artemether + Lumefantrine (Coartem) 81 86 87 90 18 86 22 86
 Quinine (inj) 74 100 54 85 22 70 24 71
 Quinine (oral) 70 100 47 88 12 63 14 64
 Artesunate na 29 na 5 na 7 na 7
 SP (IPTp) 94 na 83 na 32 na 35 na
  1. AZT zidovudine, 3TC lamivudine, D4T stavudine, SP sulfadoxine-pyrimethamine (Fansidar), IPTp intermittent presumptive treatment during pregnancy, na not applicable, inj injection, wt weighted
  2. a15 health centers in 2007 were reclassified as rural hospitals by 2012